Next Article in Journal
Preferential Incorporation of Azelaic Acid Units into the Crystalline Phase of the Copoly(Alkylene Dicarboxylate) Derived from 1,9-Nonanediol and an Equimolar Mixture of Pimelic and Azelaic Acids
Next Article in Special Issue
Microwave-Absorbing Properties of Rice Starch
Previous Article in Journal
Biocatalytic Self-Cleaning Polymer Membranes
Previous Article in Special Issue
Preparation and Properties of Cellulose Laurate (CL)/Starch Nanocrystals Acetate (SNA) Bio-nanocomposites
Open AccessArticle

Preparation and Evaluation of Vancomycin-Loaded N-trimethyl Chitosan Nanoparticles

by Jiaojiao Xu 1,2,†, Beihua Xu 2,†, Dan Shou 3, Xiaojing Xia 2 and Ying Hu 1,2,*
1
Department of Medicine, Wenzhou Medical University, Wenzhou 325000, China
2
Zhejiang Pharmaceutical College, Ningbo 315000, China
3
Department of Medicine, Zhejiang Academy of Traditional Chinese Medicine, Hangzhou 310000, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Jianxun Ding
Polymers 2015, 7(9), 1850-1870; https://doi.org/10.3390/polym7091488
Received: 14 July 2015 / Revised: 23 August 2015 / Accepted: 6 September 2015 / Published: 22 September 2015
(This article belongs to the Collection Polysaccharides)
Chronic intracellular infections caused by drug-resistant pathogens pose a challenge to the treatment of chronic osteomyelitis. Such treatment requires an intracellular delivery system for the sustained release of antibiotics such as vancomycin (VCM), which is an antibiotic of last resort used against many clinically resistant bacteria. In this work, we report VCM-loaded N-trimethyl chitosan (TMC) nanoparticles and their potential application for drug delivery. The results showed that the prepared nanoparticles were predominantly spherical in shape with an average particle diameter of 220 nm, a positive zeta potential, and a loading efficiency of 73.65% ± 1.83%. Furthermore, their drug release profile followed the Higuchi model for sustained release, with non-Fickian diffusion. Over a 24-h period, 6.51% ± 0.58% of the drug within the optimized nanoparticles was released. In vitro cytology showed that osteoblasts (OBs) exhibited higher alkaline phosphatase activity (ALP) after exposure to TMC nanoparticle material. Furthermore, TMC nanoparticles increased the uptake of water-soluble quantum dots (QDs) by OBs, and both nanoparticles and VCM/TMC mixtures improved OB proliferative activity. We also investigated the minimum inhibitory concentration (MIC, 60 μg/mL), half maximal inhibitory concentration (IC50, 48.47 μg/mL), diameter of inhibition zone (DIZ, 1.050 cm), and turbidimetric (TB) assay of nanoparticles. All data demonstrated that VCM/TMC nanoparticles had excellent antibacterial activity against the Gram-positive bacterium Staphylococcus aureus. These findings suggest that VCM-loaded TMC nanoparticles have good potential for the sustained delivery of antibiotics to bone infections. View Full-Text
Keywords: vancomycin (VCM); N-trimethyl chitosan (TMC); intracellular infections; nanoparticles vancomycin (VCM); N-trimethyl chitosan (TMC); intracellular infections; nanoparticles
Show Figures

Graphical abstract

MDPI and ACS Style

Xu, J.; Xu, B.; Shou, D.; Xia, X.; Hu, Y. Preparation and Evaluation of Vancomycin-Loaded N-trimethyl Chitosan Nanoparticles. Polymers 2015, 7, 1850-1870.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop